U.S. Markets close in 6 mins

Getinge AB (GNGBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
19.60-0.62 (-3.09%)
As of 3:10PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.23
Bid0.00 x 0
Ask0.00 x 0
Day's Range19.60 - 19.86
52 Week Range14.27 - 24.64
Avg. Volume4,046
Market Cap5.361B
Beta (5Y Monthly)0.54
PE Ratio (TTM)N/A
EPS (TTM)-0.26
Earnings DateN/A
Forward Dividend & Yield0.16 (0.79%)
Ex-Dividend DateJun 29, 2020
1y Target EstN/A
  • PR Newswire

    Getinge launches NICCI - the latest innovation in Advanced Hemodynamic Monitoring

    Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent studies[1] show that fluctuations in blood pressure may be missed due to standard intermittent readings.


    Getinge AB to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 16, 2020/ Getinge AB (OTCMKTS:GNGBY) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 16, 2020 at 10:00 AM Eastern Time.

  • PR Newswire

    The ventilation technology from Getinge that is groundbreaking both for premature babies and adults

    Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and sophisticated technology to improve outcomes for premature babies. One such technique called NAVA, invented by Getinge, utilizes sensors to help babies on ventilators breathe more easily and naturally-and it's increasingly being used on adults. And a new randomized study shows that NAVA can significantly shorten the time on the ventilator.